Learn about how one inspiring young man with the condition is thriving despite the challenges—and how Johnson & Johnson is helping him and others like him to find new ways to manage their mental illness.
From scientists in research labs to CEOs at companies across the country, here's how one healthcare company is partnering with people from all walks of life to help drive change in how we treat mental disorders—and the stigma often associated with them.
With company leaders at the World Economic Forum in Davos this week, Johnson & Johnson's Chief Scientific Officer weighs in on the next great global healthcare challenge—and how we can all come together to help address it.
From the incredible researchers who've dedicated their life's work to fighting chronic diseases to those who work tirelessly to bring hope to underserved populations, we're taking a moment to celebrate the company's many heroes.
Shortly after Fernando Salinas took custody of 4-year-old Ilio, he discovered his son had AIDS. For World AIDS Day, we're sharing his powerful story of hope, perseverance and unconditional fatherly love.
What if we could make caregivers’ lives less stressful? For National Family Caregivers Month, we're looking at how Janssen Clinical Development Director Branislav Mancevski, M.D., is helping pave the way.
Thanks to cutting-edge innovations in imaging, adherence and early intervention, mental health researchers are making crucial advances in the understanding and management of the complex condition. We delve into their work for Mental Health Awareness Month.
Husseini Manji, M.D., is working toward a world in which diseases like depression and schizophrenia are diagnosed quickly and handled without stigma. His team's discoveries in the lab may just get us there.